Global Platelet Function Testing Market Overview:
Cardiovascular diseases are the leading cause of death in the Western world. Several factors have led to the increase in vascular disorders, including the aging population, unhealthy lifestyles, increasing rates of diabetes and raised lipids, and further risk factors resulting in inflammation and calcification of the vascular endothelium. Platelets are an essential component of blood coagulation and are responsible for maintaining primary hemostasis under conditions of blood flow. There are several methods for platelet function testing (PFT), which differ with regard to the underlying detection principle, agonists, and sample material used for testing.
- Increasing Vascular Disorders, including Aging Population, Unhealthy Lifestyles, Increasing Rates of Diabetes and Others
- Growing Awareness about the Platelet Rich Plasma Therapy
- Increasing Investment in R&D
- Adoption of Technologically Advanced product in Platelet Aggregation System
- Growing Number of Surgical Procedures
- High Costs of Therapies and Devices Can Hamper the Growth of Market
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are F. Hoffmann-La Roche Ltd (Switzerland), Fresenius (Germany), Siemens (Germany), TERUMO BCT, INC. (United States), Haemonetics Corporation (United States), AggreDYNE (United States), Helena Laboratories (United States), Sysmex Corporation (Japan), Haemochrom Diagnostica GmbH (Germany), Pathway Diagnostics Limited (United Kingdom), LABiTec LAbor BioMedical Technologies GmbH (Germany), Thermo Fisher Scientific (United States), Quest Diagnostics Incorporated (United States) and PerkinElmer Inc. (United States). Additionally, following companies can also be profiled that are part of our coverage like WerfenLife, S.A. (Spain), Matis Medical Inc. (United States), Chrono-log Corporation (United States) and Drucker Diagnostics (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Platelet Function Testing market by 2025. Considering Market by Testing Type, the sub-segment i.e. Light Transmission Aggregometry (LTA) will boost the Platelet Function Testing market. Considering Market by End-Use, the sub-segment i.e. Hospitals will boost the Platelet Function Testing market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Platelet Function Testing market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Platelet Function Testing market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Platelet Function Testing Service Providers, Healthcare Industry, Regulatory Bodies, Clinical Laboratory and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.